Target intelligence / Profile preview

Vocal fold tissue

Molecular classification
Other
01

Overview

Vocal fold tissue refers to a pair of multilayered, wedge-shaped structures located in the larynx (voice box), composed of three main layers: an epithelial surface, a lamina propria (with superficial, intermediate, and deep layers rich in extracellular matrix), and an underlying vocalis muscle[1][2][5]. The tissue's extracellular matrix contains collagen, elastin, fibronectin, and proteoglycans, which together provide the viscoelastic properties essential for vibration and sound production[2][5]. The biological function of vocal fold tissue includes generation of sound (phonation), airway protection, and regulating airflow. Common diseases affecting this tissue include vocal fold scarring (fibrosis), nodules, polyps, paralysis, and cancer. "Vocal fold tissue" is not considered a therapeutic target in the molecular sense, but rather the site or substrate on which disease, injury, and therapy act[2][5]. In summary, "Vocal fold tissue" does not conform to the definition of a target molecule or receptor. It is an anatomical structure, not a protein, receptor, or gene, and is therefore not used as a canonical therapeutic or biomarker target in drug discovery or molecular pharmacology[1][2][5].

Other names
vocal cordstrue vocal foldsvocal ligamentsvocalis muscle
02

Biological functions

Voice production (phonation)Airway protectionRegulation of airflowVibration and sound modulation
03

Disease associations

Other (e.g., dysphonia, vocal fold paralysis, nodules, polyps, scarring, laryngeal cancer, Reinke's edema)
04

Safety considerations

Vocal fold tissue is delicate and integral to breathing and phonation, so surgical or pharmacological interventions risk scarring or loss of function (leading to permanent voice changes, airway compromise, or dysphonia)Steroid or anti-fibrotic treatments may have adverse effects on wound healing
05

Biomarkers

Alpha-smooth muscle actin (α-SMA) (marker for myofibroblast differentiation in vocal fold fibrosis)Collagen and elastin content/organization (histological marker of tissue health or scarring)Fibronectin, fibromodulin, decorin (ECM components relevant to fibrosis and tissue remodeling)Expression of inflammation, adhesion, or proliferation genes in disease (e.g. *IL1A*, *IL36A*, *DSG1*, *CDH3*, *NR4A3*, etc.)

Beyond the preview

Go deeper on Vocal fold tissue.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vocal fold tissue.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call